SCHEMBL6947858

SCHEMBL6947858

CCc1ccccc1N/C=C1/C(=O)N(c2cccc(NS(C)(=O)=O)c2)N=C1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.40
MEN1 O00255 6/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 9/20 0.39
MAPK1 P28482 6/20 0.39
L3MBTL1 Q9Y468 6/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 2/20 0.38
PTGS1 P23219 1/20 0.38
CYP2C9 P11712 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP2 O95551 1/20 0.38
HTT P42858 2/20 0.37
MDM2 Q00987 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
KAT8 Q9H7Z6 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
POLB P06746 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947861 1.00 KMT2A (0.40) KMT2AMEN1GAAMAPTMAPK1
SCHEMBL6949877 0.88 MEN1 (0.35) KMT2AMEN1MAPTMAPK1ALDH1A1
SCHEMBL6949879 0.88 MEN1 (0.35) KMT2AMEN1MAPTMAPK1ALDH1A1
SCHEMBL7073259 0.86 KMT2A (0.45) KMT2AMEN1GAAMAPTMAPK1
SCHEMBL7073258 0.86 KMT2A (0.45) KMT2AMEN1GAAMAPTMAPK1
SCHEMBL6950541 0.85 ALDH1A1 (0.37) KMT2AMEN1MAPTMAPK1ALDH1A1
SCHEMBL6950538 0.85 ALDH1A1 (0.37) KMT2AMEN1MAPTMAPK1ALDH1A1
SCHEMBL6952715 0.84 KMT2A (0.41) KMT2AMEN1GAAMAPTMAPK1
SCHEMBL6947878 0.84 KMT2A (0.41) KMT2AMEN1GAAMAPTMAPK1
SCHEMBL6942638 0.84 ALDH1A1 (0.47) KMT2AMEN1GAAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed